It’s IVDR Time: What’s the State of Play?

article image

The official date of application for the EU IVDR has arrived, setting into motion a multi-year rollout of compliance deadlines. Here’s a look at where things stand.

The In Vitro Diagnostics Regulation is the official law of the land in the European Union as of Thursday, May 26, when the five-year transition clock for the 2017-enacted IVDR ticks to zero. What that means can vary a bit depending on the particulars of each manufacturer and test. In response to COVID-19 challenges, the EU agreed to stretch out IVDR compliance deadlines for tests placed on the market before May 26, with risk-based phase-in dates ranging from 2025 to 2027.

But, starting now, all IVDs must comply with upgraded IVDR postmarket surveillance requirements, and any new test or test with a “significant change” will need an IVDR certificate to be placed on the market. Check out our latest Market Pathways’ Scorecard infographic, with a rundown of compliance timelines and a snapshot of the IVDR state of play. 


This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to Market Pathways:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to Market Pathways
Sign up for All-Access

Join our global community with a subscription to both MedTech Strategist and Market Pathways for one low price.



We're here to help! Please contact us at: